ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Up 15.8% in November

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 6,450,000 shares, an increase of 15.8% from the November 15th total of 5,570,000 shares. Approximately 14.1% of the shares of the stock are short sold. Based on an average daily volume of 4,620,000 shares, the days-to-cover ratio is presently 1.4 days.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. bought a new position in shares of ASP Isotopes during the third quarter valued at $42,000. The Manufacturers Life Insurance Company bought a new position in ASP Isotopes during the 3rd quarter worth $52,000. Fielder Capital Group LLC bought a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $55,000. KKM Financial LLC increased its stake in shares of ASP Isotopes by 66.2% in the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after buying an additional 9,000 shares during the period. Finally, Sanctuary Advisors LLC bought a new position in shares of ASP Isotopes during the third quarter worth about $66,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Trading Up 14.4 %

ASP Isotopes stock traded up $0.63 during trading hours on Friday, hitting $5.00. The stock had a trading volume of 5,364,095 shares, compared to its average volume of 1,872,946. The business’s 50 day simple moving average is $5.62 and its 200-day simple moving average is $3.92. ASP Isotopes has a one year low of $1.65 and a one year high of $9.33. The stock has a market cap of $356.95 million, a price-to-earnings ratio of -8.20 and a beta of 3.27. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 target price for the company.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.